Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06019988 · ClinicalTrials.gov registry record · NA
Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer
A NA study of Breast Cancer and Social Determinants of Health (SDOH), sponsored by Abramson Cancer Center at Penn Medicine.
- Active
- Registry status
- NA
- Development phase
- 2,500
- Enrollment target
- 1
- Study location
NCT06019988: Active NA study of Breast Cancer and Social Determinants of Health (SDOH), sponsored by Abramson Cancer Center at Penn Medicine.
NCT06019988 is a NA study of Breast Cancer and Social Determinants of Health (SDOH) that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2,500 participants, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06019988, a NA study of Breast Cancer and Social Determinants of Health (SDOH), is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this project is to optimize the collection of social and behavioral determinants of health (SBDOH) for patients with a pathological diagnosis of breast cancer at Penn Medicine. The investigators will measure rates of SBDOH data collection by modality and rates of referral to and uptake of social support services, time to evaluation, staff time, acceptability, patient-centered communication, medical mistrust, and clinician acceptability.
Primary Outcome
Rates of SBDOH screen completion prior to initial surgical consult will be first compared by instrument (Accountable Health Communities Health-Related Social Needs Screening Tool \[AHC-HRSN\], Health Leads Social Needs Screening Toolkit \[Health Leads\], National Comprehensive Cancer Network Distress Thermometer and Problem List \[NCCN DT + PL\]). Only the NCCN DT employs a 10-point Likert scale, where 0 = no distress and 10 = extreme distress. Among patients who do not respond to initial screen
Conditions Studied
Interventions
- OTHER Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2026-03-11 |
| Phase | NA |
What the registry record for NCT06019988 still lists
NCT06019988 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (11% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening is the first listed.
NCT06019988 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06019988 about?
NCT06019988 is a clinical study titled "Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer". The overarching goal of this project is to optimize the collection of social and behavioral determinants of health (SBDOH) for patients with a pathological diagnosis of breast cancer at Penn Medicine. The investigators will measure rates of SBDOH data collection by modality and rates of referral to ...
What is the current status of trial NCT06019988?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2024-03-11. Estimated completion is 2026-03-11.
What conditions does trial NCT06019988 study?
This clinical trial studies the following conditions: Breast Cancer, Social Determinants of Health (SDOH).
What interventions are being tested in trial NCT06019988?
The interventions under investigation include: Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening (OTHER).
Who is sponsoring clinical trial NCT06019988?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06019988 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06019988's enrollment target sits among peer trials
2,500 58th of 1224 higher than 1,167 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI